(Institución)
 
 

Docu-menta >

Statistics

Total Visits

Views
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 237

Total Visits per Month

February 2025 March 2025 April 2025 May 2025 June 2025 July 2025 August 2025
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 15 11 14 15 14 17 12

File Downloads

Views
23. Navarro- MOL THERAPY MCD 2021.pdf 129

Top Country Views

Views
España 237

Top City Views

Views
Madrid 237

 

Información y consultas: documenta@ciemat.es | Documento legal